Combined Hypoxia Therapy and Rehabilitation for Spinal Cord Injury
(HANDS Trial)
Trial Summary
What is the purpose of this trial?
The overall objective of this project is to investigate the effectiveness of daily acute intermittent hypoxia therapy (dAIH), coupled with massed practice training, to improve upper-extremity function in individuals with chronic incomplete cervical SCI.
Will I have to stop taking my current medications?
The trial requires participants to stop taking antispasticity medications if they wean off them to complete the screening session. They must refrain from these medications for the duration of the study.
What data supports the effectiveness of this treatment for spinal cord injury?
Research shows that acute intermittent hypoxia (AIH), which involves brief periods of low-oxygen breathing, can improve hand function and walking ability in people with spinal cord injuries. Studies in both humans and animal models suggest that AIH may help the nervous system recover and improve breathing and movement after injury.12345
Is combined hypoxia therapy generally safe for humans?
Research on acute intermittent hypoxia (AIH) in humans with spinal cord injuries suggests it is generally safe, as studies have shown improvements in hand strength and breathing function without significant safety concerns. However, more studies are needed to determine the optimal dosage and long-term safety.12567
How does the treatment of acute intermittent hypoxia and rehabilitation differ from other treatments for spinal cord injury?
This treatment is unique because it combines acute intermittent hypoxia (breathing low oxygen levels for short periods) with rehabilitation exercises to promote neuroplasticity (the brain's ability to reorganize itself) and improve motor function in spinal cord injury patients, which is not a standard approach in existing treatments.12457
Eligibility Criteria
This trial is for adults aged 18-75 with chronic incomplete cervical spinal cord injury, at least six months post-injury. It's open to those who've had no symptom regression for two years and can show some hand muscle control. Pregnant or nursing women and individuals with certain cardiovascular, respiratory, or metabolic conditions are excluded.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo daily acute intermittent hypoxia therapy (dAIH) combined with massed practice training to improve upper-extremity function
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Acute Intermitted Hypoxia
- Massed Practise
- Rapael Glove
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor